- Science
- Clinical Trials
- Guide to Clinical Trials Your participation makes a difference
- Clinical Trials in Children Designed to improve kids' health
- Data and Results Sharing our Results
- Integrity and Transparency Building Trust
- Diversity Equity and Representation
- Plain Language Study Results Trial Result Summaries
- Expanded Access & Compassionate Use Possible Treatment Options
- Find a Trial
- Areas of Focus
- Rare Disease Smaller populations but big impact
- Internal Medicine Extending lifespans worldwide
- Inflammation & Immunology Treatment at the molecular level
- Vaccines Preventing the spread of infections
- Oncology The science of optimism
- Anti Infectives Combatting an evolving risk
- Areas of Innovation
- Gene Therapy Breakthroughs become treatments
- Medicinal Sciences The next generation of science
- Precision Medicine Developing tailored medicines
- Maternal Immunization Protecting newborns at the start
- mRNA Technology Unleashing the next wave of scientific innovations
- Diseases & Conditions
- Coronavirus Resources
- Product Pipeline
- Research Sites
- Clinical Trials
- Products
- How Drugs are Made
- Branded vs. Generic Learn the difference
- Biologics & Biosimilars Cures found in nature
- Commitment to Quality Maintaining the highest standards
- Global Supply Strategic manufacturing locations
- Manufacturing Sites Where medicine is made in the U.S.
- Medicine Safety
- Health Literacy Learning to be well
- Treatment Choices Learning about treatment decisions
- Partnering With Patients Helping others by reporting side effects
- Tips for Patients Preventing medication errors
- Reporting Adverse Events
- Counterfeiting Preventing medication errors
- Product Safety
- Product List
- Product Contacts
- PfizerPro for Professionals
- Patient Assistance Programs
- Distributors
- How Drugs are Made
- Stories
- Newsroom
- About
- People
- Executives Our senior-most leadership
- Board Members The people steering our company
- Scientists Our experts making discoveries
- Patient Stories Our patients
- Colleague Stories Our colleagues
- Responsibility
- Ethics & Compliance Each of us is responsible
- Responsible Business Breakthroughs that change patients’ lives
- Patient Advocacy & Engagement Putting Patients First
- Global Impact Meeting urgent needs worldwide
- Diversity, Equity, and Inclusion Everyone has something to offer
- Environmental Sustainability Our responsiblity to the environment
- Human Rights Furthering dignity and worth
- Health & Safety
- Intellectual Property The benefits of fair competition
- EHS Governance
- Misinformation
- Programs & Policies
- Grants Support for independent research
- Political Partnership Supporting like-minded organizations
- Working with Healthcare Professionals Collaboration to improve lives
- Prescription Value & Pricing How to lower patient costs
- Privacy Principles Commitment to personal data privacy
- Ready for Cures Improving Access to Medicines
- Transparency in Grants Committed to Disclosure
- Policy Positions
- Investors
- Investors Overview Information for stockholders
- Why Invest Why to join us in our mission
- Events & Presentations Calendar of upcoming events
- Financial Reports Quarterly reports and more
- Investor News Announcements about our performance
- Stock Information Charts and data
- Shareholder Services Information on stock transactions
- Corporate Governance
- Corporate Governance Overview Gaining insight into our performance
- Board Committees & Charters Defining the corporate structure
- The Pfizer Board Policies Ensuring ethical leadership
- Corporate Governance FAQs Learn more about our approach
- Contact Our Directors Email any of our Directors
- Purpose
- History
- Careers
- Partners
- People
Healthcare Charitable Contributions
Pfizer Support for Not-for-Profit Organization Healthcare Related Patient Programs
Pfizer and its legacy companies have a strong tradition of funding external, independent, not-for-profit organizations to support shared goals and to demonstrate our commitment to fund programs and activities that provide broad public benefit, advance medical care and improve patient outcomes. These external, independent, not-for-profit organizations include patient advocacy groups, professional medical associations, and other U.S.-based charitable organizations with 501(c)(3) tax status. Pfizer strives to ensure that our continued alignment with external, independent, not-for-profit organizations is conducted in strict compliance with relevant laws and regulations, industry codes, external standards and internal Pfizer policies and procedures.
One category of funding that Pfizer provides to qualified 501(c)(3) organizations is "Healthcare Charitable Contributions". Pfizer provides limited support for certain healthcare related programs/activities for patients.
Definition: For purposes of Pfizer's funding of external, independent, not-for-profit organizations, programs eligible for Healthcare Charitable Contributions are limited to the following: 1) patient education, including health screening; 2) patient advocacy for disease awareness, and 3) patient access to care (e.g., transportation costs). Pfizer does not receive any significant value in terms of goods or services in return for its support. Pfizer does not support studies or research through its Healthcare Charitable Contributions program.
We recognize that there may be diverse understandings of the term Healthcare Charitable Contributions. Pfizer has its own specific definition of this term that complies with our internal policies. We encourage external, independent, not-for-profit organizations to look at other Pfizer resources for guidance on funding of activities that do not fit this definition of Healthcare Charitable Contributions. One such resource is www.pfizer.com/independentgrants.
Application Process:
- Requests for healthcare charitable contributions must be submitted according to the quarterly schedule noted below:
Application Cycle Decision Communicated
byDeadline to sign LOA Estimated
Start Date of Program/ActivityDec 1, 2023 - Jan 31, 2024 Mar 3, 2024 Minimum of 2 weeks before start date or the decision will reverse to denied April 1, 2024 or later Mar 1, 2024 - April 15, 2024 June 2, 2024 July 1, 2024 or later June 1, 2024 - July 15, 2024 Sept 1, 2024 Oct 1, 2024 or later Sept 1, 2024 - Oct 15, 2024 Dec 1, 2024 Jan 1, 2025 or later - Pfizer will not fund a patient program/activity after the start date has passed.
- The patient program/activity must be aligned with a listed area of interest, refer to the "Important Deadlines and Dates" section above for the current year's list.
- The target learner audience may not include healthcare professionals.
- If Pfizer decides to provide a healthcare charitable contribution, the organization must sign a Letter of Agreement.
- For all funded programs, the organization must complete an Acknowledgment Form following the conclusion of the patient program/activity.
Required Documents:
- A description of the program and its objectives
- IRS determination letter confirming the organization's 501(c)(3) tax status
- IRS Form W-9 Tax Identification Number and Certification
Special Note for Co-Pay Foundations
If your organization is an independent, U.S. charitable organization that operates patient assistance programs to assist patients with co-pay, deductible, and/or premium obligations, or for incidentals in connection with treatment, please do not use this portal for requesting donations from Pfizer. To learn how to submit a request for a donation, please send your name and contact details to [email protected] and a Pfizer representative will get back to you with information on our co-pay foundation donation process. Thank you.
Important Deadlines and Dates
The Application System
Submit a new application or view an existing application through our Application System